We showed that inhibition of IKKβ by both genetic and pharmacological means effectively reduced the transcription of CXCL1, CXCL2 and CXCL8 in GAB2-overexpressing FTSECs and ovarian cancer cells. The gene discussed is CXCL2; the disease is ovarian cancer.